Aims and scope
Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.
Robert Bals, Saarland University, Germany
Francesco Blasi, University of Milan, Italy
Arnaud Bourdin, University of Montpellier, France
Mario Cazzola, Antonio Cardarelli Hospital, Italy
Bruno Crestani, Bichat Hospital, France
Jeanine D'Armiento, Columbia University College of Physicians and Surgeons, USA
Massimo Di Maio, University of Turin, Italy
Louise Donnelly, Imperial College London, UK
Hiromasa Inoue, Kagoshima University, Japan
Victor Kim, Temple University School of Medicine, USA
Victor Laubach, University of Virginia, USA
Stylianos Orfanos, National and Kapodistrian University of Athens, Greece
Stephen Peters, Wake Forest University Health Sciences, USA
YS Prakash, Mayo Clinic, USA
Oliver Schildgen, Hospital of the Private University Witten/Herdecke, Germany
Dale D Tang, Albany Medical College, USA
Johan Verbraecken, Antwerp University Hospital, Belgium
Featured review: A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
The addition of inhaled corticosteroids (ICS) to long-acting β2 agonist therapy is recommended in patients with moderate-to-severe COPD. However, ICS are overprescribed in clinical practice, and most patients are unlikely to benefit from long-term ICS therapy. Evidence from randomized-controlled trials supports the hypothesis that ICS can be safely and effectively discontinued in patients with stable COPD and in whom ICS therapy may not be indicated. This article summarizes the evidence supporting the discontinuation of ICS therapy, and proposes an algorithm for the implementation of ICS withdrawal in patients with COPD in clinical practice.
Featured blog post: Vaping is less harmful than conventional smoking
With the increasing popularity of "vaping" across the world, a new study from Respiratory Research shows that regardless of flavor, vaping does less damage to the lungs than conventional smoking.
Professor at the Department of Internal Medicine, and Chairman of the Krefting Research Centre at the University of Gothenburg.
Submit your review
Sign up to receive article alerts
Respiratory Research is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.